Ian M. Rosenthal

1.7k total citations
18 papers, 1.3k citations indexed

About

Ian M. Rosenthal is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Ian M. Rosenthal has authored 18 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 9 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Ian M. Rosenthal's work include Tuberculosis Research and Epidemiology (14 papers), Cancer therapeutics and mechanisms (8 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Ian M. Rosenthal is often cited by papers focused on Tuberculosis Research and Epidemiology (14 papers), Cancer therapeutics and mechanisms (8 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Ian M. Rosenthal collaborates with scholars based in United States, Switzerland and India. Ian M. Rosenthal's co-authors include J Grosset, Kathy N. Williams, Sandeep Tyagi, William R. Bishai, Eric L. Nuermberger, Eric Nuermberger, Deepak V. Almeida, Charles A. Peloquin, Ming Zhang and Andrew Vernon and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Antimicrobial Agents and Chemotherapy and PLoS Medicine.

In The Last Decade

Ian M. Rosenthal

18 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ian M. Rosenthal United States 13 1.1k 838 417 336 169 18 1.3k
Eric Nuermberger United States 19 1.2k 1.0× 831 1.0× 308 0.7× 401 1.2× 198 1.2× 21 1.4k
Sang Nae Cho South Korea 15 1.1k 1.0× 828 1.0× 405 1.0× 359 1.1× 100 0.6× 28 1.4k
Rokeya Tasneen United States 20 1.4k 1.3× 998 1.2× 616 1.5× 367 1.1× 165 1.0× 35 1.7k
Tetsuyuki Yoshimatsu Japan 11 1.1k 1.0× 850 1.0× 412 1.0× 337 1.0× 108 0.6× 23 1.3k
Frederick A. Sirgel South Africa 18 1.2k 1.1× 984 1.2× 307 0.7× 382 1.1× 209 1.2× 24 1.5k
Kathy N. Williams United States 19 1.6k 1.5× 1.2k 1.4× 729 1.7× 455 1.4× 206 1.2× 28 1.9k
Si-Yang Li United States 18 979 0.9× 819 1.0× 416 1.0× 228 0.7× 86 0.5× 27 1.2k
Alena Skrahina Denmark 20 1.1k 1.0× 840 1.0× 229 0.5× 400 1.2× 72 0.4× 57 1.3k
Jurriaan E.M. de Steenwinkel Netherlands 18 610 0.5× 493 0.6× 250 0.6× 151 0.4× 111 0.7× 49 959
Firat Kaya United States 15 688 0.6× 471 0.6× 367 0.9× 168 0.5× 72 0.4× 30 947

Countries citing papers authored by Ian M. Rosenthal

Since Specialization
Citations

This map shows the geographic impact of Ian M. Rosenthal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian M. Rosenthal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian M. Rosenthal more than expected).

Fields of papers citing papers by Ian M. Rosenthal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian M. Rosenthal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian M. Rosenthal. The network helps show where Ian M. Rosenthal may publish in the future.

Co-authorship network of co-authors of Ian M. Rosenthal

This figure shows the co-authorship network connecting the top 25 collaborators of Ian M. Rosenthal. A scholar is included among the top collaborators of Ian M. Rosenthal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian M. Rosenthal. Ian M. Rosenthal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Loss, Manisha J., Katherine G. Thompson, Garth A. James, et al.. (2020). Noninflammatory comedones have greater diversity in microbiome and are more prone to biofilm formation than inflammatory lesions of acne vulgaris. International Journal of Dermatology. 60(5). 589–596. 10 indexed citations
2.
Bell, William R., Alan K. Meeker, Anthony Rizzo, et al.. (2018). A unique telomere DNA expansion phenotype in human retinal rod photoreceptors associated with aging and disease. Brain Pathology. 29(1). 45–52. 4 indexed citations
3.
Saab, Jad, Ian M. Rosenthal, Lu Wang, et al.. (2016). Dermatofibrosarcoma Protuberans-Like Tumor With COL1A1 Copy Number Gain in the Absence of t(17;22). American Journal of Dermatopathology. 39(4). 304–309. 7 indexed citations
4.
Rosenthal, Ian M., Janis M. Taube, Douglas L. Nelson, & Gulsun Erdag. (2013). A Case of Infraorbital Lichen Sclerosus. Dermatology Online Journal. 19(10). 20021–20021. 8 indexed citations
5.
Rosenthal, Ian M., Rokeya Tasneen, Charles A. Peloquin, et al.. (2012). Dose-Ranging Comparison of Rifampin and Rifapentine in Two Pathologically Distinct Murine Models of Tuberculosis. Antimicrobial Agents and Chemotherapy. 56(8). 4331–4340. 116 indexed citations
6.
Zhang, Ming, Si-Yang Li, Ian M. Rosenthal, et al.. (2011). Treatment of Tuberculosis with Rifamycin-containing Regimens in Immune-deficient Mice. American Journal of Respiratory and Critical Care Medicine. 183(9). 1254–1261. 46 indexed citations
7.
8.
Zhang, Tianyu, Ming Zhang, Ian M. Rosenthal, J Grosset, & Eric L. Nuermberger. (2009). Short-Course Therapy with Daily Rifapentine in a Murine Model of Latent Tuberculosis Infection. American Journal of Respiratory and Critical Care Medicine. 180(11). 1151–1157. 56 indexed citations
9.
Almeida, Deepak V., Eric L. Nuermberger, Rokeya Tasneen, et al.. (2009). Paradoxical Effect of Isoniazid on the Activity of Rifampin-Pyrazinamide Combination in a Mouse Model of Tuberculosis. Antimicrobial Agents and Chemotherapy. 53(10). 4178–4184. 79 indexed citations
10.
Rosenthal, Ian M., Ming Zhang, Deepak V. Almeida, J Grosset, & Eric Nuermberger. (2008). Isoniazid or Moxifloxacin in Rifapentine-based Regimens for Experimental Tuberculosis?. American Journal of Respiratory and Critical Care Medicine. 178(9). 989–993. 49 indexed citations
11.
Nuermberger, Eric, Sandeep Tyagi, Rokeya Tasneen, et al.. (2008). Powerful Bactericidal and Sterilizing Activity of a Regimen Containing PA-824, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis. Antimicrobial Agents and Chemotherapy. 52(4). 1522–1524. 152 indexed citations
12.
Rosenthal, Ian M., Ming Zhang, Kathy N. Williams, et al.. (2007). Daily Dosing of Rifapentine Cures Tuberculosis in Three Months or Less in the Murine Model. PLoS Medicine. 4(12). e344–e344. 168 indexed citations
13.
Rosenthal, Ian M., Kathy N. Williams, Sandeep Tyagi, et al.. (2006). Potent Twice-Weekly Rifapentine-containing Regimens in Murine Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 174(1). 94–101. 66 indexed citations
14.
Nuermberger, Eric L., Ian M. Rosenthal, Sandeep Tyagi, et al.. (2006). Combination Chemotherapy with the Nitroimidazopyran PA-824 and First-Line Drugs in a Murine Model of Tuberculosis. Antimicrobial Agents and Chemotherapy. 50(8). 2621–2625. 93 indexed citations
15.
Nuermberger, Eric, Sandeep Tyagi, Kathy N. Williams, et al.. (2005). Rifapentine, Moxifloxacin, or DNA Vaccine Improves Treatment of Latent Tuberculosis in a Mouse Model. American Journal of Respiratory and Critical Care Medicine. 172(11). 1452–1456. 58 indexed citations
16.
Rosenthal, Ian M., Kathy N. Williams, Sandeep Tyagi, et al.. (2005). Weekly Moxifloxacin and Rifapentine Is More Active Than the Denver Regimen in Murine Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 172(11). 1457–1462. 42 indexed citations
17.
Tyagi, Sandeep, Eric L. Nuermberger, Tetsuyuki Yoshimatsu, et al.. (2005). Bactericidal Activity of the Nitroimidazopyran PA-824 in a Murine Model of Tuberculosis. Antimicrobial Agents and Chemotherapy. 49(6). 2289–2293. 174 indexed citations
18.
Nuermberger, Eric, Tetsuyuki Yoshimatsu, Sandeep Tyagi, et al.. (2004). Moxifloxacin-containing Regimens of Reduced Duration Produce a Stable Cure in Murine Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 170(10). 1131–1134. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric Nuermberger Breakdown of academic impact, for papers by Sang Nae Cho Breakdown of academic impact, for papers by Rokeya Tasneen Breakdown of academic impact, for papers by Tetsuyuki Yoshimatsu Breakdown of academic impact, for papers by Frederick A. Sirgel Breakdown of academic impact, for papers by Kathy N. Williams Breakdown of academic impact, for papers by Si-Yang Li Breakdown of academic impact, for papers by Alena Skrahina Breakdown of academic impact, for papers by Jurriaan E.M. de Steenwinkel Breakdown of academic impact, for papers by Firat Kaya
Rankless by CCL
2026